AWARDBPA CALLOther than small business
BPA call 75F40123F19006DELOITTE CONSULTING LLP
Overview
Award facts
- Net obligations
- $24.33M
- $24,329,855of $25.70M potential value
- Outlays (paid to date)
- $12.48M
- $12.48M paid of $24.33M obligated$12,476,759
- Period of performance
- Dec 8, 2022 to Sep 28, 2027
- Ends in 10 months
- Modifications
- 17
- Latest action Sep 24, 2026
- Contract type
- BPA call
- PIID 75F40123F19006
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
FDA BUDGET EXECUTION AND CONTROL SUPPORT
Dates and value
- Award date
- Signed on Dec 8, 2022
- Current value
- $25,207,267Base and exercised options
- Potential value (if all options are exercised)
- $25,701,177
- Parent contract vehicle
- 75F40121A00003 (BPA, single award) — 12 orders recorded under it
Obligations by fiscal year of action
- FY2026: $11,432,814
- FY2025: $7,245,284
- FY2024: $2,808,520
- FY2023: $2,843,237
Total across 4 fiscal years: $24,329,855
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Sep 24, 2026. View on USAspending · Recipient on SAM.gov
Recipient
LocationARLINGTON, VA
UEICKV2L9GZKJK3
CAGE code1TTG5
Business sizeOther than small businessSize at award, per the contracting officer
Organization typePartnership
Parent companyDELOITTE CONSULTING LLP
Business types and certifications
For-profit organizationPartnership or LLP
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded from
- Foods; Human drugs; Devices and radiological health; National center for toxicological research; Fda other activities (fda headquaters); Animal drugs and feed; Biologics; Fda user fees (non general fund); Fda working capital fundProgram activities075-0600, 075-4613Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Beltsville, Prince Georges County, Maryland 20705-3106
- Congressional district (place of performance)
- MD-04As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- R699SUPPORT- ADMINISTRATIVE: OTHER (service)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Subject to multiple award fair opportunityMAFO
- Set-aside
- Not reported
- Contract pricing
- Labor hoursZ
Solicitation and notices
- Solicitation ID
- 75F40122Q00129(as reported)
- Solicitation date
- Aug 24, 2022
Contract details
- Service Contract Act labor standards
- No
- Government-furnished property
- Transaction uses GFE/GFPY
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Dec 8, 2022Base obligation at award: $1,796,447
- Latest action
- Sep 24, 2026 — Funding onlyModification P00017; obligation change +$3,826,333; funding only: changes obligations, not scope
- Latest substantive action
- Apr 29, 2025 — Terminated for convenienceModification P00008; obligation change -$370,723
- Latest funding action
- Sep 24, 2026 — Funding onlyModification P00017; obligation change +$3,826,333; funding only: changes obligations, not scope
- Actions by type
- Base award1
- Funding only7
- Other administrative action7
- Option exercised2
- Terminated for convenience1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- $3,826,333
- Latest action: change in base and all options
- $3,826,333
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- BPA callA
- Parent vehicle type
- BPAE
- Parent vehicle: multiple or single award
- Single awardS
- Parent vehicle agency
- Food And Drug Administration7524
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7524
- Contracting office code
- 75F401
- Transactions recorded under this award key
- 18
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7524
- Funding office code
- 75F401
- Treasury accounts
- 075-2023/2023-0600-000
- 075-2025/2025-0600-000
- 075-X-0600-000
- 075-X-4613-000
- Object classes
- 25.1: Advisory and assistance services
- 25.2: Other services from non-Federal sources
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression